General Catalyst
The company, which tailors cybersecurity offerings to health systems and providers, also appointed its first chief executive officer, Geyer Jones.
The LLM startup released its first product, a genAI-enabled staffing marketplace solution, for phase three safety testing and will use the funds to speed up further product development.
The VC firm's business venture, HATCo, announced it signed a letter of intent to purchase the nonprofit healthcare system and shift its focus to value-based care.
Holly Maloney, managing director at General Catalyst, discusses where AI is making waves in healthcare and how digital health funding will progress in 2024.
The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.
At HLTH 2023, the venture firm's CEO and the former CEO of Intermountain Health announced the formation of HATCo alongside plans to purchase a health system.
The company says its LLM has passed over 100 healthcare certifications and surpassed GPT-4 and other commercial models’ performance.
At HIMSS23, Holly Maloney, managing director of General Catalyst, discussed the promise and challenge of using artificial intelligence in healthcare.
Fire1, a remote patient monitoring company for heart failure patients, and Protai, an AI-powered drug discovery platform, scored funding.
Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.